Provider of supplements intended to make the brain more effective. The company's supplements are personalized according to the user's needs and provide on-demand focus, energy and productivity, enabling consumers who struggle with brain fog and burnout to get access to a tailored product for their unique biology and daily activities.
Arine Inc. is a San Francisco-based company that develops a medication management platform aimed at improving patient health and quality of life. Founded in 2017, Arine utilizes a clinical learning and analytic response engine to deliver data-driven clinical services. The platform aggregates and analyzes clinical, social, and behavioral data to identify and address gaps in patient care, providing tailored medication recommendations and education to patients and their care teams. By focusing on evidence-based approaches, Arine optimizes medication use, enhances patient outcomes, and aims to reduce the overall cost of care. Their commitment to continuous monitoring and evaluation ensures timely follow-up and meaningful clinical service programs, guiding patients throughout their healthcare journey.
Increasing access to care for all
OFFOR Health, founded in 2014 and based in Columbus, Ohio, is dedicated to enhancing healthcare access while reducing costs. The company operates an on-site care delivery organization that connects healthcare professionals with patients in local communities. By delivering specialist anesthesiology care teams along with necessary supplies, medications, and equipment, OFFOR Health leverages a last-mile logistics network to provide patients with improved access to care. This innovative approach aims to ensure equal access to healthcare services, ultimately lowering costs across various aspects of the healthcare system.
Atlas Labs, Inc. operates a technology platform designed to connect patients with various medical aid programs, aiming to minimize out-of-pocket expenses and alleviate the workload of financial counselors. The platform enhances revenue generation from third-party programs and assists patients in securing financial aid, while also facilitating reimbursement for medical providers on self-pay balances. By streamlining patient enrollment in external programs, Atlas Labs converts uncompensated care into revenue and automates financial assistance for those ineligible for certain programs. The company, incorporated in 2015 and headquartered in San Francisco, California, plays a crucial role in improving patient access to financial resources, demonstrating compliance, and addressing community healthcare needs.
Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.
Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing innovative male birth control solutions. The company has created Echo-V, an ultrasound-visible polymer solution that is injected into the vas deferens, forming a semi-permeable hydrogel device that blocks sperm while allowing bodily fluids to pass through. This product is part of a non-surgical procedure known as Vasintomy. Contraline's first product, Adam, utilizes a proprietary injectable hydrogel platform and is designed for a minimally invasive outpatient procedure. Adam is non-hormonal, intended to provide effective contraception for several years, and can be easily reversed. Established in 2015, Contraline aims to advance reproductive health through its unique approaches to male contraception.
Developer of a maternal health-tech software designed to connect black expectant mothers with critical resources to drive positive pregnancy outcomes. The company's platform features a free birth planning tool, and free fifteen-minute consults with doulas for interested expectant mothers, enabling medical professionals to elevate the standard of care, with a focus on improving maternal health outcomes.
Attivare Therapeutics
Seed Round in 2021
Attivare Therapeutics develops biomaterial vaccines to facilitate multiple applications.
Catena Biosciences is a biotechnology startup emerging from research at UC Berkeley, focused on developing innovative treatments for autoimmune disorders. The company has created an advanced protein coupling technology that allows for the rapid and selective fusion of proteins using natural amino acids, specifically tyrosine and cysteine. This method enhances the ability of researchers to design novel therapeutics not only for autoimmune disorders but also for oncology and vaccine development. By leveraging this unique platform, Catena Biosciences aims to transform the landscape of treatment options for these challenging medical conditions.
CareRev operates a healthcare staffing marketplace that connects healthcare facilities with flexible clinical professionals. It provides an online platform that allows hospitals and outpatient facilities to directly access per diem medical staff without the involvement of vendors or agencies. This model enables healthcare facilities to fill empty shifts more rapidly, reduce overall staffing costs, and enhance the quality of patient care by maintaining safe nurse-to-patient ratios. CareRev's platform facilitates direct communication between facilities and healthcare professionals, giving the latter the freedom to choose their working hours and locations. The company is backed by Y Combinator and a group of notable business angels, focusing on addressing the significant staffing challenges within the healthcare sector.
Vital Biosciences Inc, founded in 2016 and based in Kitchener, Canada, develops innovative tools designed to monitor health and manage diseases. The company operates as a business-to-business (B2B) vertical portal specifically tailored for the life sciences industry. By focusing on the needs of this sector, Vital Biosciences aims to enhance health monitoring and disease management solutions.
ixlayer enables leading health systems, clinical labs, biopharma, and consumer companies to offer precision health testing, by remove all the technical, security, and regulatory complexity involved in launching a clinical health test.
AmacaThera Inc. is a biotechnology company based in Toronto, Canada, established in 2016. The company specializes in developing and commercializing an innovative injectable hydrogel platform technology aimed at enhancing medical treatments. This technology is designed to localize and sustain drug delivery, thereby improving patient outcomes across various therapeutic areas. AmacaThera's hydrogel consists of a reversible and fast-gelling physical blend of hyaluronan and methylcellulose, which liquefies under force. This unique formulation assists healthcare providers in reducing post-operative pain for patients, showcasing the potential of AmacaThera's approach in addressing significant medical needs.
Concert Health, Inc. is a company based in San Diego, California, that specializes in integrating behavioral health services into medical practices. Founded in 2016, it operates an online platform that connects physicians with therapists and psychiatrists, facilitating the integration of screening, therapy, and psychiatric consultations into healthcare workflows. The company provides a range of services, including remote clinical staffing with behavioral care managers and psychiatric consultants, as well as tools for registry, screening, documentation, and billing support. Concert Health aims to enhance the quality of behavioral healthcare through evidence-based practices while enabling physician practices to capitalize on new reimbursement opportunities, particularly under Medicare's Collaborative Care Management framework.
Earli is focused on transforming cancer detection and treatment by developing innovative technologies that enable early identification of tumors. The company specializes in creating synthetic biopsies, which are designed to induce cancer cells to produce non-human synthetic biomarkers. These biomarkers can be detected in biological samples such as blood, urine, or breath, allowing for the visualization of tumors that are typically too small to identify in traditional screenings. By leveraging these programmable genetic constructs, Earli aims to provide real-time data on cancer presence and progression, facilitating personalized treatment approaches and improving the chances of successful intervention. Overall, Earli's mission is to make the experience of cancer more manageable by ensuring timely detection and response.
Developer of an active particle control technology designed to increase the overall air filtration efficiency. The company's technology removes small critical particles, such as bacteria, viruses, allergens, TVOC, gasses and odors indoors by reducing or eliminating harmful particles, enabling hospitals, commercial buildings and homes to improve air quality, prevent sick building syndrome and the spread of dangerous airborne pathogens.
Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing innovative male birth control solutions. The company has created Echo-V, an ultrasound-visible polymer solution that is injected into the vas deferens, forming a semi-permeable hydrogel device that blocks sperm while allowing bodily fluids to pass through. This product is part of a non-surgical procedure known as Vasintomy. Contraline's first product, Adam, utilizes a proprietary injectable hydrogel platform and is designed for a minimally invasive outpatient procedure. Adam is non-hormonal, intended to provide effective contraception for several years, and can be easily reversed. Established in 2015, Contraline aims to advance reproductive health through its unique approaches to male contraception.
Koneksa Health Inc. is a healthcare data analytics company based in New York, with an additional location in London. Founded in 2013, the company specializes in designing and developing software for pharmaceutical and biotech firms to facilitate decision-making and regulatory claims based on remotely generated patient data. Its flagship product, Koneksa Compare, provides a dashboard for capturing, monitoring, and analyzing patient-generated data and outcomes in clinical studies. The software supports the integration of emerging technologies, such as bio-sensors, activity trackers, and mobile-based questionnaires, allowing researchers to expand the range of analyzable data and reduce subjectivity in clinical endpoints. Koneksa Health aims to enhance the efficiency and accuracy of clinical research through its innovative solutions.
Atlas Labs, Inc. operates a technology platform designed to connect patients with various medical aid programs, aiming to minimize out-of-pocket expenses and alleviate the workload of financial counselors. The platform enhances revenue generation from third-party programs and assists patients in securing financial aid, while also facilitating reimbursement for medical providers on self-pay balances. By streamlining patient enrollment in external programs, Atlas Labs converts uncompensated care into revenue and automates financial assistance for those ineligible for certain programs. The company, incorporated in 2015 and headquartered in San Francisco, California, plays a crucial role in improving patient access to financial resources, demonstrating compliance, and addressing community healthcare needs.
Brightside Benefit, Inc. operates a financial care platform designed for employers to enhance the financial well-being of their employees. Founded in 2017 and headquartered in Chandler, Arizona, with additional offices in Philadelphia, the company provides a comprehensive solution that combines personal assistants, smart technology, and innovative financial products. Its platform, Kickforward, offers real-time guidance and personalized financial support, enabling employees to make informed decisions that improve their financial behavior and net income. Brightside emphasizes unbiased service, ensuring that employees have access to reliable financial information and options without conflicts of interest from financial institutions. By focusing on individual needs and utilizing behavioral science, Brightside aims to alleviate employee stress, ultimately driving better productivity, retention, and diversity while reducing healthcare costs for employers.
Wellth develops and operates a mobile application to lower cost for payors and rewards for consumers. Its application engages consumers through providing targeted incentive plans, delivering reminders and information, and sharing cost savings that help them build healthy habits and foster disease management. It focuses on reducing the cost of the healthcare system by encouraging consumers to manage their diseases and to take preventative actions to stay healthy. Wellth is based in New York, New York.
Lucy Goods, Inc. is a company based in Los Angeles, California, that specializes in manufacturing and selling nicotine alternatives, primarily in the form of gum and lozenges. Established in 2016, the company aims to reduce tobacco-related harm by offering next-generation nicotine products made with pure nicotine and food-grade ingredients. Lucy Goods provides its products in various flavors, including fruit, mint, and cinnamon, catering to consumer preferences. The company markets its products primarily online, positioning itself as a cleaner and more convenient alternative to conventional tobacco products.
CloudCath is a company that specializes in developing a remote monitoring platform for peritoneal dialysis patients. Their innovative system utilizes sensor-enabled technology to provide continuous monitoring, allowing for early detection of complications associated with catheter-based treatments. By leveraging Internet of Things (IoT) capabilities, CloudCath's platform enables healthcare providers to remotely oversee patients during their home treatment, significantly reducing the frequency of in-person visits. This approach not only enhances patient safety but also improves the overall management of care for individuals undergoing peritoneal dialysis, ultimately promoting better health outcomes.
Physical therapy is powerful—for developing strength, managing emerging conditions, or recovering from surgery. But it’s challenging for physical therapy to make a significant clinical impact because therapists and patients are worn out. Traditional physical therapy leaves more than 50% of therapists suffering from work-related pain and 70% of patients failing to complete their course of care. On both sides of the therapy table, people need better support. At Luna, they’re designing a practice that gives therapists and patients the independence, control, and motivation they need to feel meaningful relief.
Uniform Teeth is an orthodontics practice focused on providing modern and accessible orthodontic care. The company operates dental clinics that specialize in clear teeth aligners, which are crafted from biocompatible, BPA-free plastic designed to fit the patient's teeth at each stage of treatment. By prioritizing quality and intuitiveness in their services, Uniform Teeth aims to simplify the orthodontic experience for patients seeking to straighten their teeth.
Meissa Vaccines, Inc. is a pharmaceutical development company based in San Mateo, California, established in 2014. The company focuses on advancing vaccines for respiratory syncytial virus (RSV), rhinovirus, and human metapneumovirus, addressing significant unmet medical needs, particularly in pediatrics. By in-licensing and developing these vaccines, Meissa Vaccines aims to mitigate the impact of respiratory illnesses, which are leading causes of infectious disease globally. The successful implementation of their vaccine programs could greatly reduce the incidence of acute lower respiratory tract diseases, alleviate symptoms associated with colds and asthma exacerbations, and ultimately lessen the burden on families by minimizing school and work absenteeism. The company's initiatives not only prioritize child health but also have the potential to benefit various age groups within the community.
Buoy Health, Inc. is a health technology company based in Boston, Massachusetts, with an additional office in New York. Founded in 2014, Buoy Health specializes in artificial intelligence-driven digital health solutions that assist individuals in managing their health and healthcare options. The company offers a personalized online healthcare chatbot, known as Buoy Assistant, which analyzes symptoms, facilitates initial triage, and provides treatment recommendations. This platform enables users to conduct real-time assessments of their symptoms while simplifying the navigation of the healthcare system. Additionally, Buoy Health provides resources for employees through its Buoy Dashboard, allowing them to research benefits, access wellness programs, and connect with in-network providers. The service is available 24/7, making self-diagnosis and healthcare navigation straightforward and accessible.
Osmosis is a personalized learning platform focused on enhancing health education by providing a deeper understanding of medical concepts. The platform enables clinicians and caregivers to access a wealth of educational resources, including a comprehensive library of videos and multiple-choice questions. Driven by data and technology, Osmosis aims to improve retention and preparedness for courses and exams, making it a valuable tool for medical professionals seeking to deepen their knowledge and skills in the healthcare field. By offering tailored content that goes beyond traditional lectures, Osmosis supports effective learning for a global audience in the medical community.
Mightier is a gaming platform designed to assist children in regulating their emotions through scientifically-backed methods. Founded in 2016 and based in Boston, Massachusetts, the platform features bioresponsive video games developed in collaboration with Boston Children's Hospital and Harvard Medical School. The games utilize a biofeedback heart rate monitor that adjusts the difficulty level based on the player's emotional state, helping children learn to manage their feelings in real-time. By engaging with these interactive experiences, children with behavioral and emotional challenges can discover their emotional strengths and develop skills to harness their emotions in everyday situations.
SafeRide, Inc. is a digital health platform that specializes in non-emergency medical transportation (NEMT) services, enabling healthcare providers to efficiently book and manage rides for patients. Founded in 2015 and headquartered in San Francisco, the company offers a mobile application that allows users to schedule transportation quickly, receive appointment reminders, and track rides in real-time for enhanced safety and quality. SafeRide's services not only help prevent no-shows but also assist in identifying and managing at-risk patients before their conditions worsen. With a network that spans major cities including Los Angeles, Seattle, Portland, St. Louis, and New York, SafeRide aims to improve access to life-sustaining care for vulnerable populations while enhancing the overall patient experience and reducing healthcare costs.
Opentrons is a company focused on developing pipetting robot technology to automate laboratory experiments. By utilizing open-source principles and programming in Python, Opentrons creates automated lab equipment that streamlines various scientific processes. Their product offerings encompass lab robots, workstations, hardware modules, consumables, reagents, and labware, all designed to enhance the efficiency and accuracy of research. This automation helps scientific researchers reduce human error and expedite their experimental workflows, making lab work faster and less labor-intensive.
Sonavex, Inc. is a Baltimore-based company founded in 2013 that specializes in advanced imaging technology for surgical patients. The company's primary focus is on developing an ultrasound-based method to detect anastomotic blood clots, which are critical for patient recovery post-surgery. By providing clinicians with real-time visualization of essential data directly at the point of care, Sonavex aims to enhance clinical decision-making and improve patient outcomes. Their proprietary technology platform allows for the measurement of crucial intravascular flow metrics, enabling the early detection of post-operative clots and contributing to better overall surgical results.
SwiftShift addresses the increasing demand for pediatric home care by offering a nurse-managed service designed to facilitate the transition from hospital to home-based care. Recognizing the inefficiencies in current pediatric care models, SwiftShift replaces traditional office-based case management with self-managed nurse care teams, which fosters stronger relationships among patients, families, and nurses. The platform enables nurses to select their patients and control their schedules, enhancing job satisfaction and ownership. Additionally, SwiftShift employs an AI-based management system to streamline care delivery by providing easy access to essential patient data, allowing nurses to make informed decisions. The company is dedicated to supporting its nurses through continuous professional development and training, ensuring that high-quality care is delivered consistently. By connecting nurses and clinicians with families needing in-home care, SwiftShift not only improves patient outcomes but also offers caregivers the flexibility and financial stability they seek in their professional lives.
EpiBone, Inc. is a biotechnology company based in Brooklyn, New York, founded in 2013, that focuses on developing innovative solutions for bone reconstruction. The company employs advanced technology to create defect-specific living bone grafts by utilizing scans of a patient’s bone defect along with their own stem cells. This process involves cultivating the graft in a custom bioreactor, allowing the new bone to grow in a controlled environment. EpiBone's approach aims to deliver precise repair of bone defects, streamline surgical procedures, enhance bone formation and regeneration, and reduce recovery times. This technology presents a significant advancement for the over 900,000 patients who undergo bone-related surgeries annually, eliminating the complications typically associated with foreign body implants.
Perceptive Navigation LLC is a pre-clinical stage medical device company based in Baltimore, Maryland, focused on developing innovative interventional medical devices for the image-guided surgery market. The company's flagship product, Vu-Path, is an intracorporeal ultrasound device that combines front-viewing ultrasound imaging with a working portal for introducer needles, biopsy needles, guide wires, and therapeutic delivery. Designed to enhance the safety and efficacy of minimally-invasive procedures across various medical disciplines, including radiology, cardiology, interventional oncology, and urology, Vu-Path addresses significant limitations of existing imaging techniques. Traditional methods often involve high costs, complexity, and risks, particularly in challenging cases. By providing accurate and precise access to internal structures without occupying a lumen, Vu-Path aims to streamline surgical procedures, reduce equipment and staffing needs, and ultimately improve patient outcomes. The company was established in 2012 and continues to advance its core technology in response to unmet clinical needs in the field.
MHB Labs is a biotechnology company based in Chestnut Hill, Massachusetts, focused on developing innovative men's health products. Established in 1999, the company specializes in creating pharmaceutical solutions for conditions such as erectile dysfunction, Peyronie’s disease, and delayed orgasm. Its key product, AndroSphere, aims to enhance men's health by addressing these unmet medical needs. Additionally, MHB Labs collaborates with various partners, including a medical device start-up and a telemedicine company, to expand its product offerings and improve patient access to healthcare. The company leverages clinical insights and strategic alliances to advance its research and development initiatives, positioning itself to bring high-impact products to market effectively.
Catena Biosciences is a biotechnology startup emerging from research at UC Berkeley, focused on developing innovative treatments for autoimmune disorders. The company has created an advanced protein coupling technology that allows for the rapid and selective fusion of proteins using natural amino acids, specifically tyrosine and cysteine. This method enhances the ability of researchers to design novel therapeutics not only for autoimmune disorders but also for oncology and vaccine development. By leveraging this unique platform, Catena Biosciences aims to transform the landscape of treatment options for these challenging medical conditions.